BOSTON SCIENTIFIC CORPORATION
Clinical trial NCT04678258 updates: 1. completion date: 2026-12-31 → 2027-08-31 2. primary completion date: 2025-12-31 → 2026-08-31
Clinical trial NCT04678258 updates: 1. completion date: 2026-12-31 → 2027-08-31 2. primary completion date: 2025-12-31 → 2026-08-31
📉 **NEGATIVE** • Medium confidence analysis (64%) • Mild negative clinical indicator • Limited downside risk **Sentiment:** Negative (23%) **Content type:** Clinical